Clinical Trials Logo

Clinical Trial Summary

The investigators will test the hypothesis that markers of vascular endothelial dysfunction will be exaggerated acutely with an extreme high sodium diet compared to an extreme low-sodium diet. The investigators will compare patients with postural orthostatic tachycardia (POTS) to healthy control subjects.


Clinical Trial Description

The study will involve a crossover design in which each subject will be assessed (as below) while on a very low-sodium (10 mEq/day) diet compared with a very high-sodium diet. These acute dietary interventions will be part of the parent study ("Dietary Salt in Postural Tachcyardia Syndrome" funded by R01 HL102387) for 4-5 days at the time of the study. Dietary success will be assessed using a 24h urine for sodium and creatinine as a part of the parent study. Blood will be drawn and collected in a fasting state for future assay and analysis of the following tests: - Glucose, Insulin (glucose impairment, insulin resistance) - Fasting lipid profile - C-Reactive Protein (hsCRP) (inflammatory state) - Inflammatory cytokines (inflammatory state) - aliquots (future analysis) Pulsitile Arterial Tonometry (PAT) Protocol Calf Blood Flow in Reactive Hyperemia (CBF-RH) - venous occlusion plethysmography Evaluation of Forearm-Mediated Dilation ;


Study Design


Related Conditions & MeSH terms

  • Postural Orthostatic Tachycardia Syndrome
  • Postural Tachycardia Syndrome (POTS)
  • Tachycardia

NCT number NCT01550315
Study type Interventional
Source Vanderbilt University Medical Center
Contact
Status Completed
Phase N/A
Start date April 2012
Completion date September 2021

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02558972 - Northera Improves Postural Tachycardia Syndrome (POTS) and Postural Vasovagal Syncope (VVS) Phase 2
Recruiting NCT05421208 - Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome N/A
Recruiting NCT05375968 - Splanchnic Venous Capacitance in Postural Tachycardia Syndrome N/A
Active, not recruiting NCT02854683 - Reducing Orthostatic Intolerance With Oral Rehydration in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients Phase 1